Indo Us Bio-Tech Limited (INDOUS) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Indo Us Bio-Tech Limited stock ₹90.90, price ₹66.20, upside +37.3%, quality 47 out of 100. Rating: undervalued. Calculated from audited financials with 17 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Indo Us Bio-Tech Limited
INDOUS · NSECheap (27% below fair value), but weak company and falling price: meets 1 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 15, 2026.
How to read this chart
26‑month range ₹60.31 – ₹376.10 · fair‑value band ₹45.12 – ₹155.30 · the ₹66.20 price screens below the ₹90.90 fair value. As of Nov 15, 2026.
Every Wednesday you see whether Indo Us Bio-Tech is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Indo Us Bio-Tech Limited engages in the production, processing, packing, and marketing of seeds in India.
Show moreShow less
The company offers vegetable seeds, such as tomato, okra, bottle gourd, brinjal, carrot, cluster bean, bitter gourd, ridge gourd, cucumber, cabbage, radish, sponge gourd, pepper, chilly, sweet pepper, beet root, cow pea, corriander, onion, watermelon, musk melon, and flower seeds; cotton seeds; and oil seeds, including castor, groundnut, sesamum, mustard, and soyabean seeds.
It also provides cumin and isabgul spices seeds; pulses seeds comprising val, gram, black gram, and green gram seeds; and cereals seeds consisting of wheat, maize, bajra, and pegeon pea seeds. It also exports its products. The company was incorporated in 2004 and is based in Ahmedabad, India.
Stock analysis
Indo Us Bio-Tech Limited (INDOUS) currently trades at ₹66.20, while our model-based Fair Value estimate is ₹90.90, implying the stock looks roughly 27% undervalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ₹178.06 per share, and 13 of the 17 models we run sit above the ₹66.20 price.
Bear case: the Asset-Based group reads lowest at ₹39.96, and 4 of the 17 models stay below the price. Data coverage for this calculation is low.
Scenario range: ₹45.12 (bear) to ₹155.30 (bull), the price of ₹66.20 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 47/100 (below-average quality), in the Basic Materials sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Indo Us Bio-Tech Limited reported revenue of ₹1.1B in FY2026 versus ₹501M in FY2022, a compound +21.9%/yr. Reported net income was ₹131M in FY2026, compounding +26.9%/yr from FY2022.
Key figures
Market cap ₹1.3B (≈ $14.1M) Micro · P/E ratio 29.7 · P/S ratio 3.53 · EPS (TTM) ₹2.23 · Net margin 11.9% · Return on equity 15.3% · Return on assets (EBIT) 9.8% (5-year average) · Operating margin 13.1%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 54 out of 100 (low confidence).
What moves the price
The share trades about 56% below its 52-week high and 10% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at 17% fair-value upside, at 37%, INDOUS screens cheaper than that median.
Fair Value models
All 17 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Watch INDOUS, get fair value alerts →
Compare Indo Us Bio-Tech Limited with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Agricultural Inputs · 174 stocks
Valuation Multiplesvs Agricultural Inputs median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Consumer Staples sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- EBIT margin by industry
- P/S ratio by industry
- PEG screener for stocks with fair value
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Agricultural Inputs stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| SABIC Agri-Nutrients Company 2020 | 114.40 SAR | 150.65 SAR | +32% | vs INDOUS |
| The Mosaic Company MOS | $21.92 | $28.58 | +30% | vs INDOUS |
| Asia-potash International Investment (Guangzhou)Co.,Ltd., 000893 | ¥29.91 | ¥38.01 | +27% | vs INDOUS |
| Qinghai Salt Lake Industry Co 000792 | ¥21.62 | ¥26.81 | +24% | vs INDOUS |
| Nutrien Ltd NTR | $71.24 | $83.09 | +17% | vs INDOUS |
| ICL Group ICL | $4.52 | $4.86 | +7% | vs INDOUS |
| Yara International ASA YAR | kr 405.70 | kr 424.51 | +5% | vs INDOUS |
| CF Industries Holdings CF | $125.09 | $114.88 | −8% | vs INDOUS |
| Yunnan Yuntianhua Co 600096 | ¥26.06 | ¥17.67 | −32% | vs INDOUS |
| Coromandel International Limited COROMANDEL | ₹1,969 | ₹1,129 | −43% | vs INDOUS |
Explore undervalued stocks
More undervalued Basic Materials stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Indo Us Bio-Tech Limited (INDOUS) overvalued or undervalued?
What is the fair value of INDOUS?
What is the quality score of INDOUS?
What is the price target for Indo Us Bio-Tech Limited (INDOUS)?
What is the Indo Us Bio-Tech Limited stock forecast for 2026?
What is the revenue of Indo Us Bio-Tech Limited (INDOUS)?
What is the intrinsic value of Indo Us Bio-Tech Limited (INDOUS)?
Is Indo Us Bio-Tech Limited stock overvalued or undervalued in 2026?
Is fair value the same as the market price of INDOUS?
How much is Indo Us Bio-Tech Limited worth?
What do the bullish and bearish scenarios say about INDOUS?
What is the P/E ratio of INDOUS?
How solid is the balance sheet of Indo Us Bio-Tech Limited (INDOUS)?
How far is INDOUS from its 52-week high?
Which stocks are comparable to Indo Us Bio-Tech Limited?
Is Indo Us Bio-Tech Limited stock attractive at the current price?
How is the fair value of INDOUS calculated?
Is it still worth investing in stocks now?
What is the share price of Indo Us Bio-Tech Limited (INDOUS)?
What should I pay attention to with Indo Us Bio-Tech Limited right now?
Key figures of Indo Us Bio-Tech Limited
How large is the market capitalisation of Indo Us Bio-Tech Limited (INDOUS)?
What is the P/S ratio of Indo Us Bio-Tech Limited (INDOUS)?
What are the earnings per share of Indo Us Bio-Tech Limited (INDOUS)?
What is the net margin of Indo Us Bio-Tech Limited (INDOUS)?
What is the return on equity of Indo Us Bio-Tech Limited (INDOUS)?
What is the EBIT return on assets of Indo Us Bio-Tech Limited (INDOUS)?
What is the operating margin of Indo Us Bio-Tech Limited (INDOUS)?
How fast is revenue growing at Indo Us Bio-Tech Limited (INDOUS)?
How fast are earnings growing at Indo Us Bio-Tech Limited (INDOUS)?
How much free cash flow does Indo Us Bio-Tech Limited (INDOUS) generate?
How much net debt does Indo Us Bio-Tech Limited (INDOUS) carry?
Watch Indo Us Bio-Tech Limited in the live analysis
One click puts Indo Us Bio-Tech Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.